Literature DB >> 3135710

MR flow imaging in vascular malformations using gradient recalled acquisition.

W M Needell1, K R Maravilla.   

Abstract

Twenty patients with known or suspected intracranial vascular lesions were evaluated with gradient recalled MR (GRASS) imaging, and the results were compared with those obtained by standard spin-echo MR, CT, and angiography. GRASS imaging with a short TR (40 msec) and a partial flip angle (60 degrees or 70 degrees) demonstrated flow-related enhancement within vascular structures in nearly all cases. The only exception to the enhancement of flowing blood was when slow flow was encountered within venous structures oriented parallel to the imaging plane, in which case flow signal void occurred. GRASS imaging was particularly useful for differentiating flowing blood from calcium or air, or for delineating vascular structures adjacent to the inner table of the skull. The major limitation of the technique is the presence of hemosiderin, which causes marked signal dropout due to the exquisite sensitivity of GRASS to magnetic susceptibility effects.

Entities:  

Mesh:

Year:  1988        PMID: 3135710      PMCID: PMC8332019     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

1.  Selective magnetic resonance angiography of the head.

Authors:  H P Mattle; K U Wentz
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jan-Feb       Impact factor: 2.740

2.  Comparison of magnetic resonance angiography, magnetic resonance imaging and conventional angiography in cerebral arteriovenous malformation.

Authors:  F Nüssel; H Wegmüller; P Huber
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 3.  Imaging Inflammation - From Whole Body Imaging to Cellular Resolution.

Authors:  Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.